Author:
Iyer Vivek N.,Apala Dinesh R.,Pannu Bibek S.,Kotecha Aditya,Brinjikji Waleed,Leise Michael D.,Kamath Patrick S.,Misra Sanjay,Begna Kebede H.,Cartin-Ceba Rodrigo,DuBrock Hilary M.,Krowka Michael J.,O'Brien Erin K.,Pruthi Rajiv K.,Schroeder Darrell R.,Swanson Karen L.
Reference62 articles.
1. Diagnosis and management of gastrointestinal bleeding in patients with hereditary hemorrhagic telangiectasia;Longacre;Am J Gastroenterol,2003
2. High rates of bleeding complications among hospitalized patients with hereditary hemorrhagic telangiectasia in the United States;Brinjikji;Ann Am Thorac Soc,2016
3. Bevacizumab;Kazazi-Hyseni;Oncologist,2010
4. Plasma level and tissue expression of angiogenic factors in patients with hereditary hemorrhagic telangiectasia;Sadick;Int J Mol Med,2005
5. Patients with hereditary hemorrhagic telangiectasia have increased plasma levels of vascular endothelial growth factor and transforming growth factor-beta1 as well as high ALK1 tissue expression;Sadick;Haematologica,2005
Cited by
92 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献